Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Immunomedics

Gilead To Buy Cancer Drugmaker Immunomedics For $21 Billion

Gilead's offer will be funded with $15 billion in cash on hand, and through $6 billion in newly issued debt, according to the drugmaker.

Read More

Gilead To Buy Cancer Drugmaker Immunomedics For $21 Billion

The offer will be funded with $15 billion in cash on hand, and through $6 billion in newly issued debt, according to the drugmaker.

Read More